FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly therapy, cardiology. It can be used for prediction of risk of renal venous blood flow disturbance in patients with arterial hypertension. Investigations are carried out in a complex manner, including determination of body weight index, ultrasonography and echocardiography. Active physical activity and alcohol consumption are taken into account.
EFFECT: method enables detecting disturbed venous blood flow, correcting the antihypertensive therapy if necessary, reducing the risk of developing renal failure.
1 cl, 1 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING HYPERTENSIVE DISEASE WITH CONCOMITANT VENOUS SYSTEM PATHOLOGY AND CONNECTIVE TISSUE DYSPLASIA | 2023 |
|
RU2818548C1 |
| METHOD OF DETERMINATION OF HYPERTENSIVE DISEASE TYPE | 1992 |
|
RU2019126C1 |
| METHOD FOR DIAGNOSING RISK OF DEVELOPING A SYNDROME OF VEGETATIVE-VASCULAR DYSFUNCTION IN SCHOOL-AGE CHILDREN WHEN EXPOSED TO ENVIRONMENTAL FACTORS | 2017 |
|
RU2646582C1 |
| DEVICE MEASURING TEMPERATURE | 1996 |
|
RU2104504C1 |
| METHOD OF OUTCOME FORECAST OF DISEASE OF PATIENTS WITH URGENT SURGICAL PATHOLOGY OF ORGANS OF ABDOMINAL CAVITY | 2007 |
|
RU2352948C1 |
| METHOD OF ASSESSING EFFECTIVENESS OF VITAMIN D THERAPY FOR CHRONIC KIDNEY DISEASE IN PERSON WITH DIABETES MELLITUS | 2022 |
|
RU2806735C1 |
| METHOD FOR PREDICTING IMPROVEMENT OF RENAL HEMODYNAMICS 6 MONTHS AFTER PROCEDURE OF SYMPATHETIC DENERVATION OF RENAL ARTERIES IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION COMBINED WITH TYPE 2 DIABETES MELLITUS | 2023 |
|
RU2807270C1 |
| METHOD FOR DIAGNOSTICS OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | 2017 |
|
RU2641964C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF NEPHROPROTECTION IN SELECTING THE PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION ASSOCIATED WITH TYPE 2 DIABETES MELLITUS FOR THE SYMPATHETIC RENAL DENERVATION OF RENAL ARTERIES | 2019 |
|
RU2728093C1 |
| METHOD FOR COMPLEX EVALUATING THE SEVERITY OF HEMODYNAMIC AND METABOLIC DISORDERS IN WOMEN AT PERIMENOPAUSAL PERIOD | 2003 |
|
RU2251971C1 |
